Estimating the benefits of reduced fracture incidence for patients living with osteogenesis imperfecta and for healthcare payers
| Main Authors: | , , , , , , |
|---|---|
| Format: | Conference item |
| Jezik: | English |
| Izdano: |
International Society for Pharmacoeconomics and Outcomes Research
2024
|